They tested the type II diabetes–related genes in LPS-induced RAW 264.7 cells and found that LPS could greatly increase the levels of RANTES, 11β-HSD1, and PPARγ genes; however, type II diabetes–related genes decreased signifcantly in the cordycepin-treated group. This evidence concerns the gene CCL5 and type 2 diabetes mellitus.